Search


PDF Archive search engine
Last database update: 18 May at 13:36 - Around 76000 files indexed.


Show results per page

Results for «biomarkers»:


Total: 53 results - 0.061 seconds

CV2016 Updated 100%

Spanish, German Research interests My main research interests have been a combination of clinical and basic cancer research (translational), including biomarkers for early detection of cancer, predictive and prognostic biomarkers, genome-wide analysis and mechanisms of treatment resistance.

https://www.pdf-archive.com/2018/04/22/cv2016-updated/

22/04/2018 www.pdf-archive.com

ER1234 94%

2ND r INTERNATIONAL NTNU SYMPOS UM 5 CURRENT AND FUTURE CLINICAL BIOMARKERS OF CANCER NTE i RNR T I ON H NTNU L SYMPOSIUMON i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i i C L(N I Cfi L B l0M RRKERSO FCANCER From diagnosis to immunotherapy - why is precision medicine so difficult?

https://www.pdf-archive.com/2019/06/11/er1234/

11/06/2019 www.pdf-archive.com

shortCV 92%

gcohen@stat.ubc.ca Education Postdoctoral Fellow University of British Columbia, 2005-2007 Statitical Proteomics, Department of Statitics Biomarkers in Transplantation Ph.D.

https://www.pdf-archive.com/2017/02/18/shortcv/

18/02/2017 www.pdf-archive.com

ER1235 85%

ESMO ADVANCED COURSE PROGRAMME LUNG CANCER IN IMMUNOTHERAPY A NEW PARADIGM WITH UNANSWERED QUESTIONS Zurich, Switzerland 3-4 July 2019 CO-CHAIRS Aurelien Marabelle, France SPEAKERS John Haanen, Netherlands Maurice Perol, France Solange Peters, Switzerland David Planchard, France LEARNING OBJECTIVES Understanding the key players in tumour immunology Getting up-to-date on the role of immunotherapy in advanced NSCLC The role of biomarkers in selecting NSCLC patients for IT Mechanism of combining angiogenesis inhibition with checkpoint inhibition Management of IT toxicity and use of IT in specific subgroups of patients ACCREDITATION The programme of this event has been accredited with 10 ESMO-MORA category 1 points.

https://www.pdf-archive.com/2019/06/11/er1235/

11/06/2019 www.pdf-archive.com

Boston Biomarker Poster 03192014 82%

A MULTIANALYTE ALGORITHM PCR-BASED BLOOD TEST OUTPERFORMS SINGLE ANALYTE ELISA-BASED BLOOD TESTS FOR NEUROENDOCRINE TUMOR DETECTION A key issue in management of neuroendocrine tumors (NETs) is specific and sensitive biomarkers.

https://www.pdf-archive.com/2014/03/21/boston-biomarker-poster-03192014/

21/03/2014 www.pdf-archive.com

JDIT-2014-1110-007 81%

www.openmedscience.com Commentary Article Choosing a target for targeted radionuclide therapy using biomarkers to personalize treatment William C.

https://www.pdf-archive.com/2017/05/30/jdit-2014-1110-007/

29/05/2017 www.pdf-archive.com

EHF2017 soheilinezhad 79%

Quantitative neuroimaging has recently revealed disrupted brain networks in migraine, and discovering such neuroimaging biomarkers may enlighten disease mechanisms and guide future disease-modifying clinical trials.

https://www.pdf-archive.com/2017/12/07/ehf2017-soheilinezhad/

07/12/2017 www.pdf-archive.com

27th Consensus Conference 78%

PD-1 targeting immunotherapy in NSCLC 15:20 - 15:40 20min Salvage PD-1 targeting therapy in unselected NSCLC 15:40 - 16:00 20min PD-L1 as a biomarker for PD-1 targeting therapy 16:00 - 16:20 20min Other biomarkers for PD-1 targeting therapy 16:20 - 16:30 10min Q&A 16:30 - 16:40 10min Closing remark KCSG 두경부암 분과장 윤환중 등록 및 식사안내 교통 및 주차 안내 ▶▶ 등록비 ▶▶ 오시는 구 사전등록 현장등록 교수, 전문의, 박사급 연구원 30,000원 40,000원 전임의, 전공의, 간호사 석사급 이하 연구원 및 학생 공보의, 군의관 20,000원 30,000원 교수, 전문의, 박사급 연구원 40,000원 50,000원 전임의, 전공의, 간호사 석사급 이하 연구원 및 학생 공보의, 군의관 30,000원 40,000원 기타, 업체 참가 50,000원 60,000원 좌장:

https://www.pdf-archive.com/2018/04/06/27th-consensus-conference/

06/04/2018 www.pdf-archive.com

26th Consensus Conference 76%

Biomarkers in colorectal cancer :

https://www.pdf-archive.com/2018/04/06/26th-consensus-conference/

06/04/2018 www.pdf-archive.com

Project SENTINEL EN R092013R6 75%

Reverse-engineering of biomarkers development patterns:

https://www.pdf-archive.com/2013/09/17/project-sentinel-en-r092013r6/

17/09/2013 www.pdf-archive.com

Project SENTINEL Venture R092013R7 75%

Reverse-engineering of biomarkers development patterns:

https://www.pdf-archive.com/2013/09/20/project-sentinel-venture-r092013r7/

20/09/2013 www.pdf-archive.com

ER1032 71%

How to use the relevant molecular biomarkers in AML in the older patient with AML?

https://www.pdf-archive.com/2018/06/20/er1032/

20/06/2018 www.pdf-archive.com

2826 Pathology Meeting program 69%

updated classification, molecular insights, biomarkers and targeted therapy Dr.

https://www.pdf-archive.com/2018/08/08/2826pathology-meetingprogram/

08/08/2018 www.pdf-archive.com

Sword ELISA Booster SUMMARY 63%

          Sword ELISA Booster Sword Diagnostics is developing a new plug-in performance booster for ELISA assays to enable trace detection of biomarkers and offer researchers:

https://www.pdf-archive.com/2015/02/10/sword-elisa-booster-summary/

10/02/2015 www.pdf-archive.com

Treatment of Neuroinflammation in Alzheimer's Disease. 60%

Clinical biomarkers of Alzheimer’s Disease include amyloid-beta plaques and tau neurofibrillary tangles.

https://www.pdf-archive.com/2018/01/29/treatment-of-neuroinflammation-in-alzheimer-s-disease/

29/01/2018 www.pdf-archive.com

JDIT-2018-0210-030 59%

NUCLEOSIDE TRANSPORTERS AS CHEMOTHERAPEUTIC TARGETS AND BIOMARKERS OF DRUG RESPONSE 1 M ovement of physiologic nucleosides and hydrophilic nucleoside analogues across biological membranes is mediated by nucleoside transport proteins.

https://www.pdf-archive.com/2018/02/21/jdit-2018-0210-030/

20/02/2018 www.pdf-archive.com

cv-pantel 58%

ERC-2016-PoC-DL3 “Advanced platform for profiling of therapeutic targets and functional analysis of circulating tumour cells in cancer patients” DISSECT, 8/2011 – 7/2016, 60 calendar months ERC Advanced Investigator Grant ERC-2010-AsG_20100317 “Disseminating tumour cells as novel biomarkers:

https://www.pdf-archive.com/2018/03/19/cv-pantel/

19/03/2018 www.pdf-archive.com

07d0c77d5987f908461f9f7c33741941 55%

Anthony Zietman, MD 10:45 am Biomarkers to select patients for active surveillance vs treatment Speaker:

https://www.pdf-archive.com/2018/07/15/07d0c77d5987f908461f9f7c33741941/

15/07/2018 www.pdf-archive.com

ER1097 53%

genomic and transcriptomic profiling in the pursuit of biomarkers.

https://www.pdf-archive.com/2018/08/23/er1097/

23/08/2018 www.pdf-archive.com

33rd Consensus Conference 50%

Management of brain metastasis in NSCLC patients with driver mutation 홍민희(연세의대) 15min Case presentation 안희경(가천의대) 10:45-11:10 25min Radiation oncologist's perspective 노재명(성균관의대) 11:10-11:35 25min Medical oncologist's perspective 최윤지(고려의대) 11:35-11:50 15min Discussion and voting 11:50-12:10 20min Coffee break Luncheon Symposium 40min Biomarkers in lung cancer:

https://www.pdf-archive.com/2018/04/06/33rd-consensus-conference/

06/04/2018 www.pdf-archive.com